BWFA
IMGN

Baltimore-Washington Financial Advisors’s Immunogen Inc IMGN Stock Holding History

Baltimore-Washington Financial Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-106
Closed -$1K – 265
2015
Q3 		$1K Buy
+106
New +$1.55K ﹤0.01% 261
2013
Q4 		– Sell
-1,450
Closed -$25K – 324
2013
Q3 		$25K Buy
+1,450
New +$25.5K 0.01% 145

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Baltimore-Washington Financial Advisors's IMGN Position: Q4 2015 in Review

Baltimore-Washington Financial Advisors sold out of Immunogen Inc (IMGN) in Q4 2015, closing a stake of 106 shares — an estimated $1K sold.

Baltimore-Washington Financial Advisors first reported a position in IMGN in Q3 2013 and held it in 2 quarters. The position peaked at $25K in Q3 2013. 152 funds tracked by Wall St. Rank hold IMGN as of Q4 2015.

  • Baltimore-Washington Financial Advisors reported no remaining Immunogen Inc position as of Q4 2015 after selling out during the quarter.
  • Baltimore-Washington Financial Advisors sold 106 Immunogen Inc shares in Q4 2015, an estimated $1K.
  • Baltimore-Washington Financial Advisors first reported a position in Immunogen Inc in Q3 2013 and held it in 2 quarters.
  • Baltimore-Washington Financial Advisors's Immunogen Inc position peaked at $25K in Q3 2013.
  • 152 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2015.

Based on Baltimore-Washington Financial Advisors's 13F filing for Q4 2015, filed 1 Feb 2016.